EGF and lung carcinoma: From a methodological point of view, the study shows the usefulness of the multivariate causal inference approach to identify a good combination of predictive biomarkers and to illustrate the application of this methodology for the identification of subgroups of advanced lung cancer patients with good and bad probabilities of success with CIMAvax-EGF.